Aller au contenu

Zepbound Returns to CVS Caremark as Massachusetts Faces Equity Pushback on GLP-1 Cuts — October 01, 2026

1 octobre 2026 · 10 min

Notes de l’épisode

Zepbound is back on CVS Caremark's standard commercial formulary starting October 1, but employers still decide, while Massachusetts critics press the state to undo its GLP-1 weight-loss coverage cuts. Plus a JAMA Health Forum Medicaid study on prior authorization, Lilly-sponsored ACHIEVE-4 heart-safety data for Foundayo in The Lancet, and California's new CalRx GLP-1 law.

In this episode
  1. CVS Caremark Adds Zepbound Back October 1, 2026: What to Ask HR Before Open Enrollment — Skinnyvip

    CVS Caremark Adds Zepbound Back October 1, 2026: What to Ask HR Before Open Enrollment # CVS Caremark Adds Zepbound Back October 1, 2026: What to Ask HR Before Open Enrollment Dr. SkinnyVIP September 15, 2026 ~9 min read Formulary details current as of September 15, 2026 This guide summarizes CVS Caremark’s May 28, 2026 announcement and standard commercial formulary template as of the…

  2. Critics say GLP-1 coverage shift raises equity issues — The Boston Globe

    # Critics say GLP-1 coverage shift raises equity issues Author: Alison Kuznitz Published: 2026-09-30T21:56:03.616000+00:00 Source: bostonglobe.com (bostonglobe.com) Language: en ## Story Critics say GLP-1 coverage shift raises equity issues # Critics say GLP-1 coverage shift raises equity issues A woman holds a Wegovy injector pen in her Wenatchee, Wash., home, on June 3, 2024. M. SCOTT…

  3. Medicaid Coverage of Obesity GLP-1s May Shift From Diabetes Version — Drugtopics

    # Medicaid Coverage of Obesity GLP-1s May Shift From Diabetes Version Published: 2026-09-30T14:00:00+00:00 Source: drugtopics.com (drugtopics.com) Language: en ## Story --- ## title: "Medicaid Coverage of Obesity GLP-1s May Shift From Diabetes Version" description: "Medicaid coverage of obesity-labeled GLP-1 receptor agonists may substitute for, rather than simply add to, diabetes-labeled…

  4. Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study — EurekAlert!

    Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study # Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study By PR Newswire | September 30, 2026,…

  5. Newsom signs law allowing California-made GLP-1 drugs — Redding

    Newsom signs law allowing California-made GLP-1 drugs # California’s GLP-1 law could expand access to obesity treatment Ernesto Centeno Araujo USA TODAY NETWORK Sept. 29, 2026, 4:42 p.m. PT Gov. Gavin Newsom recently signed a law that would allow California to make and distribute a generic version of a popular class of weight-loss drugs through the state's CalRx program. California…

Daily TopFive for GLP-1 Daily. Links above go to the original articles. Follow and rate GLP-1 Daily on Apple Podcasts. Feedback? Email [email protected].

Tous les épisodes de GLP-1 Daily: Ozempic & Wegovy News

Paramètres

Affichage

Langue

Détermine les stations affichées en premier sur la page d’accueil.

Historique

Les stations et épisodes écoutés récemment et tes dernières recherches sont seulement enregistrés dans ce navigateur.

Notifications

Un court message quand un podcast que tu suis publie un nouvel épisode. Désactive un podcast précis avec la cloche sur sa page.

Compte

Enregistrez vos favoris – dans l’app et sur le site.

Raccourcis clavier

/
Ouvrir la recherche
Espace
Lecture ou pause
← →
Dans le lecteur : 15 s en arrière, 30 s en avant (épisodes) · dans une rangée : tuile suivante
↑ ↓
Dans une rangée : cible dans la tuile
Début / Fin
Dans une rangée : première ou dernière tuile
Esc
Fermer la fenêtre ou le menu
?
Cet aperçu
En cours de lecture

Voir la station

À suivre

    Ajoutez des épisodes avec « À suivre » – ils seront lus après l'épisode en cours.